A photo accompanying this release is available at http://www.globenewswire.com/newsroom/prs/?pkgid=23097
Available in several storage capacities, the HEco Series provides a 20% reduction in nitrogen usage and consumes 30% less energy than comparable freezers. The next generation line has been engineered to provide additional functionality along with maximum storage density, industry-leading hold time and continued unsurpassed sample security.
"Equipment reliability and efficiency is absolutely critical in the cryopreservation of biological materials," said
Chart BioMedical is a leading manufacturer of cryogenic freezers, vacuum insulated products, and cryogenic systems. Applications for these products include medical laboratories, biotech/pharmaceutical companies, research facilities, blood and tissue banks, veterinary laboratories, repositories, and artificial insemination operations. For more information about Chart BioMedical or the MVE HEco Series freezers, please visit www.chartbiomed.com.
Chart is a leading independent global manufacturer of highly engineered equipment used in the production, storage and end-use of hydrocarbon and industrial gases. The majority of Chart's products are used throughout the liquid gas supply chain for purification, liquefaction, distribution, storage and end-use applications. Chart has domestic operations located across
Ken WebsterVice President, Chief Accounting Officer and Controller 216-626-1216 firstname.lastname@example.org Jim FischmanDirector of Investor Relations and Financial Planning 216-626-1216 email@example.com